tailieuchung - The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

Đang chuẩn bị liên kết để tải về tài liệu:
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

Thục Quyên 83 11 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Little is known about the relationship between preoperative body mass index and need for adjuvant radiation therapy (RT) following radical prostatectomy. The goal of this study was to evaluate the utility of body mass index in predicting adverse clinical outcomes which require adjuvant RT among men with organ-confined prostate cancer (PCa). |

Đang chuẩn bị liên kết để tải về tài liệu:
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

The impact of physical fitness and body mass index in children on the development of acute mountain sickness: A prospective observational study

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

The impact of body mass index on shortterm surgical outcomes after laparoscopic hepatectomy, a retrospective study

Impact of body mass index on surgical outcomes of gastric cancer

Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: A multi-centre cohort study

Feasibility and impact of Creciendo Sanos, a clinic-based pilot intervention to prevent obesity among preschool children in Mexico City

The impact of allergic rhinitis on the management of asthma in a working population

Comparing the functional impact of knee replacements in two cohorts

Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: A Nationwide Cohort Study

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study

Đang chuẩn bị liên kết để tải về tài liệu: The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer